2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Protein-protein interactions are considered as one of the next generation of therapeutic targets. Specific tools thus need to be developed to tackle this challenging chemical space. In an effort to derive some common principles from recent successes, we have built 2P2Idb (freely accessible at http://2p2idb.cnrs-mrs.fr), a hand-curated structural database dedicated to protein-protein interactions with known orthosteric modulators. It includes all interactions for which both the protein-protein and protein-ligand complexes have been structurally characterized. A web server provides links to related sites of interest, binding affinity data, pre-calculated structural information about protein-protein interfaces and 3D interactive views through java applets. Comparison of interfaces in 2P2Idb to those of representative datasets of heterodimeric complexes has led to the identification of geometrical parameters and residue properties to assess the druggability of protein-protein complexes. A tool is proposed to calculate a series of biophysical and geometrical parameters that characterize protein-protein interfaces. A large range of descriptors are computed including, buried accessible surface area, gap volume, non-bonded contacts, hydrogen-bonds, atom and residue composition, number of segments and secondary structure contribution. All together the 2P2I database represents a structural source of information for scientists from academic institutions or pharmaceutical industries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, many PPI modulators have been developed and some of these have even successfully entered the clinic [30–33].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [31]
Experimental — accuracy not yet measuredIn the citing paper
“To date, numerous modulators have been developed to target PPIs, and many of them have successfully entered the clinic.312–316”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [313]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
Laurie, A. T. R., & Jackson, R. M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti315 · Cited by 1,047
SURFNET: A program for visualizing molecular surfaces, cavities, and intermolecular interactions
Laskowski, R. A. (1995) · Journal of Molecular Graphics · doi:10.1016/0263-7855(95)00073-9 · Cited by 1,002
PIC: Protein Interactions Calculator
Tina, K. G., Bhadra, R., & Srinivasan, N. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm423 · Cited by 867
Protein–protein interaction inhibitors get into the groove
Mullard, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3680 · Cited by 243
Morelli, X., Bourgeas, R., & Roche, P. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.024 · Cited by 223 · cited 1×
“Over the last decade more and more orthosteric PPI modulators have been reported, and hundreds of small molecule inhibitors have now been developed for more than 40 PPI targets (4).”
BackgroundSelf-citationUsing VMD: An Introductory Tutorial
Hsin, J., Arkhipov, A., Yin, Y., Stone, J. E., & Schulten, K. (2008) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0507s24 · Cited by 212
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
Ali, S., Hassan, M., Islam, A., & Ahmad, F. (2014) · Current Protein & Peptide Science · doi:10.2174/1389203715666140327114232 · Cited by 447
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Predicting Protein–Protein Interactions from the Molecular to the Proteome Level
Keskin, O., Tuncbag, N., & Gursoy, A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00683 · Cited by 369
Druggable protein–protein interactions – from hot spots to hot segments
London, N., Raveh, B., & Schueler-Furman, O. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.10.011 · Cited by 223
Hot spots in protein–protein interfaces: Towards drug discovery
Cukuroglu, E., Engin, H. B., Gursoy, A., & Keskin, O. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.06.003 · Cited by 177
Soares, P., Gadd, M. S., Frost, J., Galdeano, C., Ellis, L., Epemolu, O., Rocha, S., Read, K. D., & Ciulli, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00675 · Cited by 165
Flexibility and small pockets at protein–protein interfaces: New insights into druggability
Jubb, H., Blundell, T. L., & Ascher, D. B. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.01.009 · Cited by 155
Hiruma, Y., Hass, M. A. S., Kikui, Y., Liu, W.-M., Ölmez, B., Skinner, S. P., Blok, A. J., Kloosterman, A., Koteishi, H., Löhr, F., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.006 · Cited by 128
Intrinsic Disorder, Protein–Protein Interactions, and Disease
Uversky, V. N. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.06.005 · Cited by 128
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
Macalino, S. J. Y., Basith, S., Clavio, N. A. B., Chang, H., Kang, S., & Choi, S. (2018) · Molecules · doi:10.3390/molecules23081963 · Cited by 125
Rules of Engagement: GPCRs and G Proteins
Glukhova, A., Draper-Joyce, C. J., Sunahara, R. K., Christopoulos, A., Wootten, D., & Sexton, P. M. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00026 · Cited by 123
Targeting protein–protein interactions, a wide open field for drug design
Bakail, M., & Ochsenbein, F. (2016) · Comptes Rendus. Chimie · doi:10.1016/j.crci.2015.12.004 · Cited by 117
Villoutreix, B. O., Kuenemann, M. A., Poyet, J., Bruzzoni‐Giovanelli, H., Labbé, C., Lagorce, D., Sperandio, O., & Miteva, M. A. (2014) · Molecular Informatics · doi:10.1002/minf.201400040 · Cited by 116
Peptiderive server: derive peptide inhibitors from protein–protein interactions
Sedan, Y., Marcu, O., Lyskov, S., & Schueler-Furman, O. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw385 · Cited by 110
Hot-spot analysis for drug discovery targeting protein-protein interactions
Rosell, M., & Fernández-Recio, J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430763 · Cited by 105
“residues and more nonpolar atoms than those of standard heterodimeric complexes [85].”
BackgroundMethodLabbé, C. M., Laconde, G., Kuenemann, M. A., Villoutreix, B. O., & Sperandio, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.003 · Cited by 104
Global vision of druggability issues: applications and perspectives
Hussein, H. A., Geneix, C., Petitjean, M., Borrel, A., Flatters, D., & Camproux, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.021 · Cited by 102
Sable, R. V., & Jois, S. D. S. (2015) · Molecules · doi:10.3390/molecules200611569 · Cited by 99
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions
Higueruelo, A. P., Jubb, H., & Blundell, T. L. (2013) · Database · doi:10.1093/database/bat039 · Cited by 93
Raux, B., Voitovich, Y. V., Derviaux, C., Lugari, A., Rebuffet, E., Milhas, S., Priet, S., Roux, T., Trinquet, E., Guillemot, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01708 · Cited by 90
Self-citationBasse, M.-J., Betzi, S., Morelli, X., & Roche, P. (2016) · Database · doi:10.1093/database/baw007 · Cited by 83
Self-citationIn silico structure-based approaches to discover protein-protein interaction-targeting drugs
Shin, W.-H., Christoffer, C. W., & Kihara, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.006 · Cited by 82
Mignani, S. M., Kazzouli, S. E., Bousmina, M., & Majoral, J. (2013) · Chemical Reviews · doi:10.1021/cr400362r · Cited by 82
HawkRank: a new scoring function for protein–protein docking based on weighted energy terms
Feng, T., Chen, F., Kang, Y., Sun, H., Liu, H., Li, D., Zhu, F., & Hou, T. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0254-7 · Cited by 79
Villoutreix, B. O., Lagorce, D., Labbé, C. M., Spérandio, O., & Miteva, M. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.013 · Cited by 78
Protein-protein interactions: Methods, databases, and applications in virus-host study
Farooq, Q. U. A., Shaukat, Z., Aiman, S., & Li, C. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i6.288 · Cited by 77
Sudha, G., Nussinov, R., & Srinivasan, N. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.07.004 · Cited by 74
AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein–Protein Interaction Interfaces
Rooklin, D. W., Wang, C., Katigbak, J., Arora, P. S., & Zhang, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00103 · Cited by 72
The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics
Cox, R. M., & Plemper, R. K. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00459 · Cited by 69
Kuenemann, M. A., Spérandio, O., Labbé, C. M., Lagorce, D., Miteva, M. A., & Villoutreix, B. O. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.02.006 · Cited by 64
Structure-based inhibition of protein–protein interactions
Watkins, A. M., & Arora, P. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.047 · Cited by 64
Structure-based assessment and druggability classification of protein–protein interaction sites
Alzyoud, L., Bryce, R. A., Sorkhy, M. A., Atatreh, N., & Ghattas, M. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12105-8 · Cited by 62
iPPI-DB: an online database of modulators of protein–protein interactions
Labbé, C. M., Kuenemann, M. A., Zarzycka, B. A., Vriend, G., Nicolaes, G. A. F., Lagorce, D., Miteva, M. A., Villoutreix, B. O., & Spérandio, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv982 · Cited by 62
Rational design of protein–protein interaction inhibitors
Rognan, D. (2015) · MedChemComm · doi:10.1039/c4md00328d · Cited by 61
Balancing novelty with confined chemical space in modern drug discovery
Medina‐Franco, J. L., Martínez‐Mayorga, K., & Meurice, N. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.872624 · Cited by 58
Cierpicki, T., & Grembecka, J. (2015) · Immunological Reviews · doi:10.1111/imr.12244 · Cited by 53
Survey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
Structural Systems Pharmacology: The Role of 3D Structures in Next-Generation Drug Development
Duran‐Frigola, M., Mosca, R., & Aloy, P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.004 · Cited by 51
Hamon, V., Bourgeas, R., Ducrot, P., Théret, I., Xuereb, L., Basse, M. J., Brunel, J. M., Combes, S., Morelli, X., & Roche, P. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0860 · Cited by 50
Self-citationLaine, E., & Carbone, A. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004580 · Cited by 45
Atypical activation of the G protein Gαq by the oncogenic mutation Q209P
Maziarz, M., Leyme, A., Marivin, A., Luebbers, A., Patel, P. P., Chen, Z., Sprang, S. R., & Garcia‐Marcos, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005291 · Cited by 45
Zhang, X., Betzi, S., Morelli, X., & Roche, P. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.57 · Cited by 44
Self-citationThe Use of Chlorobenzene as a Probe Molecule in Molecular Dynamics Simulations
Tan, Y. S., Spring, D. R., Abell, C., & Verma, C. S. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500215x · Cited by 44
Protein–Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery
Milhas, S., Raux, B., Betzi, S., Derviaux, C., Roche, P., Restouin, A., Basse, M.-J., Rebuffet, E., Lugari, A., Badol, M., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00286 · Cited by 44
Self-citationCartier-Michaud, A., Bailly, A.-L., Betzi, S., Shi, X., Lissitzky, J., Zarubica, A., Sergé, A., Roche, P., Lugari, A., Hamon, V., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006803 · Cited by 43
Self-citationKastritis, P. L., Rodrigues, J., & Bonvin, A. M. J. J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci4005332 · Cited by 43
Which three-dimensional characteristics make efficient inhibitors of protein–protein interactions?
Kuenemann, M. A., Bourbon, L. M. L., Labbé, C. M., Villoutreix, B. O., & Sperandio, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500487q · Cited by 42
Miller, T. W., Amason, J., Garcin, E. D., Lamy, L., Dranchak, P. K., MacArthur, R., Braisted, J. C., Rubin, J. S., Burgess, T. L., Farrell, C. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218897 · Cited by 37
Haque, M. M., Bayachou, M., Tejero, J., Kenney, C. T., Pearl, N. M., Im, S., Waskell, L. A., & Stuehr, D. J. (2014) · FEBS Journal · doi:10.1111/febs.13073 · Cited by 36
An Overview of Computational Methods, Tools, Servers, and Databases for Drug Repurposing
Sarvagalla, S., Syed, S. B., & Coumar, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00025-0 · Cited by 36
Loving, K. A., Lin, A., & Cheng, A. C. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003741 · Cited by 36
Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions
Nasr, A. B., Ponnala, D., Sagurthi, S. R., Kattamuri, R. K., Marri, V. K., Gudala, S., Lakkaraju, C., Bandaru, S., & Nayarisseri, A. (2015) · Bioinformation · doi:10.6026/97320630011307 · Cited by 36
Docking-based identification of small-molecule binding sites at protein-protein interfaces
Rosell, M., & Fernández‐Recio, J. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.029 · Cited by 34
Hamon, V., Brunel, J. M., Combes, S., Basse, M. J., Roche, P., & Morelli, X. (2013) · MedChemComm · doi:10.1039/c3md00018d · Cited by 31
Self-citationEngineered protein scaffolds as leads for synthetic inhibitors of protein–protein interactions
Wuo, M. G., & Arora, P. S. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.013 · Cited by 30
Structure-guided design of small-molecule therapeutics against RSV disease
Cox, R. M., & Plemper, R. K. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1174212 · Cited by 30
Ligandability and druggability assessment via machine learning
Palma, F. D., Abate, C., Decherchi, S., & Cavalli, A. (2023) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1676 · Cited by 30
The Conundrum of the High-Affinity NGF Binding Site Formation Unveiled?
Covaceuszach, S., Konarev, P. V., Cassetta, A., Paoletti, F., Svergun, D. I., Lamba, D., & Cattaneo, A. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.3485 · Cited by 29
Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics
Cossins, B., & Lawson, A. (2015) · Molecules · doi:10.3390/molecules200916435 · Cited by 29
Fragment-based drug discovery and protein–protein interactions
Turnbull, A. P., Boyd, S., & Walse, B. (2014) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28428 · Cited by 29
Melagraki, G., Ntougkos, E., Papadopoulou, D., Rinotas, V. E., Leonis, G., Douni, E. K., Afantitis, A., & Kollias, G. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00800 · Cited by 29
Recent Advances in Computational Models for the Study of Protein–Peptide Interactions
Kilburg, D., & Gallicchio, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.06.002 · Cited by 29
Sinha, C., Nischal, A., Bandaru, S., Kasera, P., Rajput, A., Nayarisseri, A., & Khattri, S. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150112114337 · Cited by 29
AlphaSpace 2.0: Representing Concave Biomolecular Surfaces Using β-Clusters
Katigbak, J., Li, H., Rooklin, D. W., & Zhang, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00652 · Cited by 28
Prediction and targeting of GPCR oligomer interfaces
Barreto, C. A. V., Baptista, S. J., Preto, A. J., Matos‐Filipe, P., Mourão, J., Melo, R., & Moreira, I. S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.11.007 · Cited by 27
Zhang, Z., Martiny, V. Y., Lagorce, D., Ikeguchi, Y., Alexov, E., & Miteva, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110884 · Cited by 27
Gudala, S., Khan, U., Kanungo, N., Bandaru, S., Hussain, T., Parihar, M. S., Nayarisseri, A., & Mundluru, H. P. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8191 · Cited by 26
The Gαi-GIV binding interface is a druggable protein-protein interaction
DiGiacomo, V., de Opakua, A. I., Papakonstantinou, M. P., Nguyen, L. T., Merino, N., Blanco‐Canosa, J. B., Blanco, F. J., & Garcia‐Marcos, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-08829-7 · Cited by 24
Gray, T. A., Murray, E., Nowicki, M. W., Remnant, L., Scherl, A., Müller, P., Vojtesek, B., & Hupp, T. R. (2013) · Protein Science · doi:10.1002/pro.2299 · Cited by 24
Dockground resource for protein recognition studies
Collins, K. W., Copeland, M. M., Kotthoff, I., Singh, A., Kundrotas, P. J., & Vakser, I. A. (2022) · Protein Science · doi:10.1002/pro.4481 · Cited by 24
Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
Voter, A. F., & Keck, J. L. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.07.005 · Cited by 24
Decoding Protein-protein Interactions: An Overview
Slater, O., Miller, B., & Kontoyianni, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200226105312 · Cited by 23
Kilburg, D., & Gallicchio, E. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00022 · Cited by 23
Bandaru, S., Ponnala, D., Lakkaraju, C., Bhukya, C. K., Shaheen, U., & Nayarisseri, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3759 · Cited by 23
Learning Universal Representations of Intermolecular Interactions with ATOMICAPreprint
Fang, A., Desgagné, M., Zhang, Z., Zhou, A., Loscalzo, J., Pentelute, B. L., & Žitnik, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.02.646906 · Cited by 22
Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2218641 · Cited by 22
Regad, L., Chéron, J.-B., Triki, D., Senac, C., Flatters, D., & Camproux, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182972 · Cited by 22
Towards the Next Generation of Computational Chemogenomics Tools
Rognan, D. (2013) · Molecular Informatics · doi:10.1002/minf.201300054 · Cited by 22
Houot, L., Navarro, R., Nouailler, M., Duché, D., Guerlesquin, F., & Lloubès, R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786061 · Cited by 22
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00545 · Cited by 21
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
Moustaqil, M. D., Gambin, Y., & Sierecki, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072301 · Cited by 21
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
Sinha, C., Nischal, A., Pant, K. K., Bandaru, S., Nayarisseri, A., & Khattri, S. (2014) · Bioinformation · doi:10.6026/97320630010611 · Cited by 21
Liu, J., Kurella, V. B., LeCour, L. F., Vanagunas, T., & Worthylake, D. K. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00745 · Cited by 20
Zhang, F., Yuan, Y., Xiang, M., Guo, Y., Li, M., Liu, Y., & Pu, X. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00850 · Cited by 19
Composition of Overlapping Protein-Protein and Protein-Ligand Interfaces
Mohamed, R., Degac, J., & Helms, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140965 · Cited by 18
Lund, B. A., Thomassen, A. M., Nesheim, B. H. B., Carlsen, T. J. O., Isaksson, J. M., Christopeit, T., & Leiros, H. S. (2018) · FEBS Journal · doi:10.1111/febs.14643 · Cited by 18
Gupta, N., Gupta, A., Kumar, S., Mishra, R., Singh, C. S., & Tripathi, A. K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5314 · Cited by 18
McDuffie, E., Panettieri, R. A., & Scott, C. P. (2024) · Respiratory Research · doi:10.1186/s12931-024-02920-0 · Cited by 17
Salah, K. B. H., Legrand, B., Das, S. K., Martínez, J., & Inguimbert, N. (2015) · Biopolymers · doi:10.1002/bip.22641 · Cited by 17
Xu, D. D., Si, Y., & Meroueh, S. O. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00181 · Cited by 16
Lagarde, N., Carbone, A., & Sacquin‐Mora, S. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25506 · Cited by 16
Senarisoy, M., Barette, C., Lacroix, F., Bonis, S. D., Stelter, M., Hans, F., Kleman, J.-P., Fauvarque, M., & Timmins, J. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b01023 · Cited by 16
Computational probing protein–protein interactions targeting small molecules
Wang, Y., Chen, S., Deng, N.-Y., & Wang, Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv528 · Cited by 15
Benchmark Study Based on 2P2IDB to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors
Wang, Z., Kang, Y., Li, D., Sun, H., Dong, X., Yao, X., Xu, L., Chang, S., Li, Y., & Hou, T. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b12658 · Cited by 15
Protein-Protein Interactions: Structures and Druggability
Ascher, D. B., Jubb, H. C., Pires, D. E. V., Ochi, T., Higueruelo, A. P., & Blundell, T. L. (2015) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-94-017-9719-1_12 · Cited by 14
Metadata
- Authors
- Basse, M. J., Betzi, S., Bourgeas, R., Bouzidi, S., Chetrit, B., Hamon, V., Morelli, X., & Roche, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Roche, Philippe
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-30
- Volume
- 41
- Issue
- D1
- Pages
- D824-D827
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3531195
- OpenAlex
- W2138314961
- Cited by
- 148
- References
- 29
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 12 · 2019: 5 · 2018: 16 · 2017: 16 · 2016: 16 · 2015: 23 · 2014: 19 · 2013: 18
- FWCI
- 20.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Agence Nationale de la Recherche
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- protein-protein interaction, structural database, protein-ligand complex, protein-protein interfaces, druggability, heterodimeric complex, binding affinity, web server
- MeSH terms
- Software, User-Computer Interface, Protein Structure, Secondary, Internet, Protein Interaction Mapping, Databases, Protein, Multiprotein Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.